Interview with Sonia Martinez, from Marco Drugs & Compounding

Use cases 1 min read
<span id="hs_cos_wrapper_name" class="hs_cos_wrapper hs_cos_wrapper_meta_field hs_cos_wrapper_type_text" style="" data-hs-cos-general-type="meta_field" data-hs-cos-type="text" >Interview with Sonia Martinez, from Marco Drugs & Compounding</span>

Sonia Martinez is the Owner of Marco Drugs and Compounding, a Miami-based compounding pharmacy.

We have interviewed her to know what her first feelings were towards CurifyLabs technology, right after starting working with our Printer!

You can listen to her in English, as well as in Spanish.

 

In English:

 

In Spanish:

Related Articles

Press release: Key IP Acquisition and Appointment of Lead Hardware Engineer

CurifyLabs Strengthens Market Position in Personalized Medicine Robotics with Key IP Acquisition and Appointment of Lead Hardware Engineer

The Medicine Maker Presents CurifyLabs' New Excipient Base: CuraBlend®Vet

Discover CuraBlend®Vet, CurifyLabs' new excipient base for stress-free veterinary compounding with broad compatibility and high palatability for pets. Now available with digital integration.

Every Fifth Extemporaneously Manufactured Dosage Form Does Not Meet The Targeted Strength Criteria

Veterinary drug treatment is often challenging due to size and body mass variations, as well as pharmacokinetic inter-species variability. The availability of approved veterinary products is relatively small, consequently leading to the need for extemporaneous manufacturing.
Blog

Mass Customization of Medicines

Mass customization is required for optimal treatments of the future. This excellent article by Siiskonen, Malmqvist and Folestad (2021) describes the potentoal of mass customization.
Blog

Inkjet printing could have a place in the manufacture of tomorrow’s medicines.

This article by Stephanie Sutton was published on the Medicine Maker forum 09/25/2015 Although our September cover feature focused on 3D printing, it is not the only printing technique that is being investigated in pharma applications; inkjet printing could also have a place in the manufacture of tomorrow’s medicines.
Blog

Managing Aspirin Hypersensitivity in Heart Patients: A New Path Forward

Discover how aspirin desensitization using 3D-printed micro-tablets offers a safe and effective solution for heart patients with aspirin hypersensitivity.
Blog

CurifyLabs Leads €5.6M EU-Funded RoboPharma Project and raised €6.7M to Modernise Personalised Medicine!

CurifyLabs raises €6.7M and leads a €5.6M EU-funded RoboPharma project to revolutionize the manufacturing of personalized medicine with automation and AI.
Press Releases

Bringing together One Medicine Research and Healthcare for Humans and Animals

Curify is proud to partner with Utrecht University's Faculty of Veterinary Medicine in establishing UTOMIC: the Utrecht Translational One Medicine Innovation Centre.
Blog